Hypermethylation of FBN2 has been previously reported in RCC (34%) [17] as well as several other cancer types including small cell lung cancer [25], esophageal squamous cell carcinoma [26] and colorectal cancer, in which it was potentially associated with hepatic metastasis [27]. Here, FBN2 is linked to renal cell carcinoma.